Evidence map›Paper›PMID 39687247›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2024

[Challenges and strategies in the response to the measles outbreak during the COVID-19 Pandemic in Mexico, 25 Years after eliminationDesafios e estratégias na resposta ao surto de sarampo durante a pandemia de COVID-19 no México, 25 anos pós-eliminação].

Santa Elizabeth Ceballos-Liceaga, Nadia María Romualdo-Tello, Paulina Sánchez-Novoa, Luisa Sosa Laso, Guillermo Carbajal Sandoval, Edith Cruz-Ramírez, Kathia Landín-Martínez, Carolina Leriche-Ramírez, Herlinda García-Lozano, Irma López Martínez and 3 more

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Santa Elizabeth Ceballos-LiceagaDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Nadia María Romualdo-TelloPrograma Especial de Inmunización integral Organización Panamericana de la Salud Washington D.C. Estados Unidos de América Programa Especial de Inmunización integral, Organización Panamericana de la Salud, Washington D.C., Estados Unidos de América.
Paulina Sánchez-NovoaConsultora independiente Consultora independiente.
Luisa Sosa LasoDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Guillermo Carbajal SandovalDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Edith Cruz-RamírezDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Kathia Landín-MartínezDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Carolina Leriche-RamírezDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Herlinda García-LozanoDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Irma López MartínezInstituto de Diagnóstico y Referencia Epidemiológicos Ciudad de México México Instituto de Diagnóstico y Referencia Epidemiológicos, Ciudad de México, México.
Gabriel García-RodríguezDirección General de Epidemiología Ciudad de México México Dirección General de Epidemiología, Ciudad de México, México.
Ruy López-RidauraSubsecretaría de Prevención y Promoción de la Salud Ciudad de México México Subsecretaría de Prevención y Promoción de la Salud, Ciudad de México, México.
José Luis Díaz OrtegaCentro Nacional para la Salud de la Infancia y la Adolescencia Ciudad de México México Centro Nacional para la Salud de la Infancia y la Adolescencia, Ciudad de México, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Identify the challenges that Mexico faced during the measles outbreak during the COVID-19 pandemic and describe the interventions to interrupt measles virus circulation. Methods: Descriptive, retrospective study of actions taken during the measles outbreak during the COVID-19 pandemic. Results: Epidemiological surveillance of febrile exanthematous diseases has been carried out continuously in the country since 1992. This measles outbreak demonstrated the limitations and strengths of the health system with respect to measles control in the context of a pandemic. Conclusions: A very important factor in controlling the outbreak was to strengthen the training and coordination of rapid response teams belonging to local health districts, states, the national network of government-operated public health laboratories, and the national laboratory supporting epidemiological surveillance (LAVE). On 31 August 2020, after 90 days of active surveillance and reports of negative test results from the network of health units and laboratory units, it was concluded that the country remained free of measles transmission.

Indexed as

COVID-19 pandemicsdisease outbreakemergenciesMeaslesMexico

Identifiers

PMID39687247
PMCPMC11648207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.